Items where authors include "Akil, M"

Article

Tarn, JR, Howard-Tripp, N, Lendrem, DW et al. (48 more authors) (2019) Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials. The Lancet Rheumatology, 1 (2). e85-e94. ISSN 2665-9913

Hackett, KL, Davies, K, Tarn, J et al. (32 more authors) (2019) Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome. RMD Open, 5 (1). e000885. ISSN 2056-5933

McCarthy, EM, Sutton, E, Nesbit, S et al. (18 more authors) (2018) Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register. Rheumatology, 57 (3). pp. 470-479. ISSN 1462-0324

Dumusc, A, Ng, W-F, James, K et al. (27 more authors) (2018) Comparison of ESSDAI and ClinESSDAI in potential optimization of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry. Swiss Medical Weekly, 148 (56). w14588. ISSN 1424-7860

Peytrignet, S, Denton, CP, Lunt, M et al. (60 more authors) (2018) Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology, 57 (2). pp. 370-381. ISSN 1462-0324

Oni, C, Mitchell, S, James, K et al. (31 more authors) (2017) Eligibility for clinical trials in primary Sjögren’s syndrome: lessons from the UK Primary Sjögren’s Syndrome Registry. Rheumatology, 56 (12). p. 2255. ISSN 1462-0324

Bezzina, OM, Gallagher, P, Mitchell, S et al. (30 more authors) (2017) Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the discrepancy. Arthritis Care and Research, 69 (11). pp. 1714-1723. ISSN 2151-464X

Herrick, AL, Pan, X, Peytrignet, S et al. (61 more authors) (2017) Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Annals of the Rheumatic Diseases, 76 (7). pp. 1207-1218. ISSN 0003-4967

McCarthy, EM, Sutton, E, Nesbit, S et al. (18 more authors) (2017) Corrigendum: The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. Rheumatology, 56 (6). p. 1049. ISSN 1462-0324

McCarthy, EM, Sutton, E, Nesbit, S et al. (18 more authors) (2017) The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. Rheumatology, 56 (6). pp. 1041-1043. ISSN 1462-0324

Howard Tripp, N, Tarn, J, Natasari, A et al. (29 more authors) (2016) Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines. RMD Open, 2 (2). e000282.

Oni, C, Mitchell, S, James, K et al. (30 more authors) (2016) Eligibility for clinical trials in primary Sjögren’s syndrome: lessons from the UK Primary Sjögren’s Registry (UKPSSR). Rheumatology, 55 (3). pp. 544-552. ISSN 1462-0324

Lendrem, D, Mitchell, S, McMeekin, P et al. (28 more authors) (2015) Do the EULAR Sjögren’s syndrome outcome measures correlate with health status in primary Sjögren’s syndrome? Rheumatology, 54 (4). pp. 655-659. ISSN 1462-0324